Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
D Brandsma, L Stalpers, W Taal, P Sminia… - The lancet …, 2008 - thelancet.com
Since the introduction of chemoradiotherapy with temozolomide as the new standard of care
for patients with glioblastoma, there has been an increasing awareness of progressive and …
for patients with glioblastoma, there has been an increasing awareness of progressive and …
Pseudoprogression, radionecrosis, inflammation or true tumor progression? Challenges associated with glioblastoma response assessment in an evolving …
The wide variety of treatment options that exist for glioblastoma, including surgery, ionizing
radiation, anti-neoplastic chemotherapies, anti-angiogenic therapies, and active or passive …
radiation, anti-neoplastic chemotherapies, anti-angiogenic therapies, and active or passive …
Incorporating diffusion-and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients
Background Pseudoprogression is a diagnostic challenge in early posttreatment
glioblastoma. We therefore developed and validated a radiomics model using …
glioblastoma. We therefore developed and validated a radiomics model using …
Imaging glioblastoma posttreatment: progression, pseudoprogression, pseudoresponse, radiation necrosis
SB Strauss, A Meng, EJ Ebani… - Neuroimaging …, 2021 - neuroimaging.theclinics.com
Eighty percent of all malignant primary brain tumors diagnosed in the United States are
gliomas. 1 The current treatment paradigm for high-grade gliomas (grades III and IV) …
gliomas. 1 The current treatment paradigm for high-grade gliomas (grades III and IV) …
Pseudoprogression and pseudoresponse in the treatment of gliomas
D Brandsma, MJ van den Bent - Current opinion in neurology, 2009 - journals.lww.com
Both pseudo-phenomenona confuse the assessment of outcome of brain tumours in clinical
practice and in clinical trials. To overcome these issues, alternative endpoints and response …
practice and in clinical trials. To overcome these issues, alternative endpoints and response …
Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group
C Erker, B Tamrazi, TY Poussaint, S Mueller… - The Lancet …, 2020 - thelancet.com
Response criteria for paediatric high-grade glioma vary historically and across different
cooperative groups. The Response Assessment in Neuro-Oncology working group …
cooperative groups. The Response Assessment in Neuro-Oncology working group …
[HTML][HTML] The diagnosis and treatment of pseudoprogression, radiation necrosis and brain tumor recurrence
K Parvez, A Parvez, G Zadeh - International journal of molecular sciences, 2014 - mdpi.com
Radiation therapy is an important modality used in the treatment of patients with brain
metastatic disease and malignant gliomas. Post-treatment surveillance often involves serial …
metastatic disease and malignant gliomas. Post-treatment surveillance often involves serial …
Head and Neck Squamous Cell Carcinoma: Value of Diffusion-weighted MR Imaging for Nodal Staging1
V Vandecaveye, F De Keyzer, V Vander Poorten… - Radiology, 2009 - pubs.rsna.org
Purpose: To evaluate diffusion-weighted (DW) magnetic resonance (MR) imaging, as
compared with turbo spin-echo MR imaging, for the detection of nodal metastases in head …
compared with turbo spin-echo MR imaging, for the detection of nodal metastases in head …
Diffusion-weighted and Perfusion MR Imaging for Brain Tumor Characterization and Assessment of Treatment Response1
JM Provenzale, S Mukundan, DP Barboriak - Radiology, 2006 - pubs.rsna.org
Diffusion-weighted magnetic resonance (MR) imaging and perfusion MR imaging are
advanced techniques that provide information not available from conventional MR imaging …
advanced techniques that provide information not available from conventional MR imaging …
Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies
N Verma, MC Cowperthwaite, MG Burnett… - Neuro …, 2013 - academic.oup.com
Differentiating treatment-induced necrosis from tumor recurrence is a central challenge in
neuro-oncology. These 2 very different outcomes after brain tumor treatment often appear …
neuro-oncology. These 2 very different outcomes after brain tumor treatment often appear …